Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Abroad (travel likely)RecruitingPHASE2
Conditions
Ovarian Cancer · Ovarian Carcinoma · Endometrial Cancer · Uterine Cancer · Cervical Cancer · Vulvar Cancer · Gynecologic Cancer · Vaginal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Panagiotis Konstantinopoulos, MD, PhD) · Panagiotis_Konstantinopoulos@dfci.harvard.edu · 617-632-2334Contact: Principal Investigator (Panagiotis Konstantinopoulos, MD, PhD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Panagiotis Konstantinopoulos, MD, PhD) · Panagiotis_Konstantinopoulos@dfci.harvard.edu · 617-632-2334Contact: Principal Investigator (Panagiotis Konstantinopoulos, MD, PhD)
Study leads
Panagiotis Konstantinopoulos, MD, PhD
Principal Investigator
Dana-Farber Cancer Institute